Similarly, in chronic myeloid leukemia, MTSS1 is downregulated, and re-expression of MTSS1 affects leukemic cell motility, tumor growth, and chronic myeloid leukemia development in vitro (Schemionek et al., 2016). Here, MTSS1 is linked to neoplasm.